GlassScriptPhysician profile
Jasmine Hernandez
NPI 1487034617
$775.54
in general payments reported to CMS, 2019-2025
12 companies · $136 in 2025
The $136 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $74.45 · 2022: $208 · 2023: $131 · 2024: $226 · 2025: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $435 · Long Term Medical Supply Or Device Loan: $58.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $434.96 |
| Long Term Medical Supply Or Device Loan | $58.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $162.07 | 2021-2025 | |
| Acclarent, INC | $130.45 | 2021-2022 | |
| Smith+Nephew, INC. | $104.27 | 2021-2025 | Tula |
| Integra Lifesciences Corporation | $102.27 | 2024-2025 | Acell, Relieva Spinplus Nav, Trudi Probe |
| Glaxosmithkline, LLC. | $85.52 | 2022-2023 | Nucala |
| Regeneron Healthcare Solutions, INC. | $64.75 | 2021-2023 | Dupixent |
| Aerin Medical INC. | $46.65 | 2024 | |
| Amgen INC. | $22.03 | 2025 | |
| Stryker Corporation | $18.99 | 2025 | Smartlock, Vsp System, Vsp Cranial, Na |
| Medtronic, INC. | $13.30 | 2021 | |
| Merck Sharp & Dohme LLC | $12.90 | 2023 | |
| Kaleo, INC. | $12.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jasmine Hernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.